Sex differences in comorbidity at diagnosis of multiple sclerosis

Neurology

Volumn 86, Issue 14, 2016, Pages 1279-1286

  Marrie, Ruth Ann ^a,b   Patten, Scott B ^c   Tremlett, Helen ^f   Wolfson, Christina ^g   Warren, Sharon ^h   Svenson, Lawrence W ^c,i   Jette, Nathalie ^c,d,e   Fisk, John ^j  

^a Departments of Internal Medicine   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Department of Community Health Sciences ^*  (Canada)

^d Institute for Public Health   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h Faculty of Medicine   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j DALHOUSIE UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BIPOLAR DISORDER; CANADIAN; CHRONIC LUNG DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; EPILEPSY; FEMALE; FIBROMYALGIA; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 84963595314     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002481     Document Type: Article

References (39)

1. Baumeister H, Balke K, Hrter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J Clin Epidemiol 2005;58: 1090-1100.
2. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-1233.
3. Vendrame M, Auerbach S, Loddenkemper T, Kothare S, Montouris G. Effect of continuous positive airway pressure treatment on seizure control in patients with obstructive sleep apnea and epilepsy. Epilepsia 2011;52:e168-e171.
4. Marrie RA, Horwitz RI, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology 2009;72:117-124.
5. Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010;74:1041-1047.
6. Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler 2015;21:263-281.
7. Jain N, Bhatti MT. Fingolimod-associated macular edema: incidence, detection, and management. Neurology 2012; 78:672-680.
8. Fromont A, Binquet C, Rollot F, et al. Comorbidities at multiple sclerosis diagnosis. J Neurol 2013;260: 2629-2637.
9. Marrie RA, Horwitz RI, Cutter G, Tyry T, Vollmer T. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand 2011;124:135-141.
10. Health Information Management Branch. Population Report. Winnipeg, Canada: Manitoba Health and Healthy Living; 2008.
11. British Columbia Ministry of Health [creator]. 2012. Discharge Abstract Database (Hospital Separations) [online]. Available at: http://www.popdata.bc.ca/data. Accessed April 1, 2015.
12. British Columbia Ministry of Health [creator]. 2012. Medical Services Plan (MSP) [online]. Available at: http://www.popdata.bc.ca/data. Accessed April 1, 2015.
13. British Columbia Ministry of Health [creator]. 2012. Consolidation File (MSP Registration & Premium Billing) [online]. Available at: http://www.popdata.bc.ca/data. Accessed April 1, 2015.
14. Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010;74:465-471.
15. Marrie RA, Fisk J, Stadnyk K, et al. The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada. Can J Neurol Sci 2013;40:824-831.
16. Marrie RA, Yu B, Leung S, et al. Rising prevalence of vascular comorbidities in MS: validation of administrative definitions for diabetes, hypertension, hyperlipidemia. Mult Scler 2012;18:1310-1319.
17. Marrie RA, Yu BN, Leung S, et al. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 2013;40:85-92.
18. Marrie RA, Fisk JD, Yu BN, et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol 2013;13:16.
19. Marrie RA, Yu BN, Leung S, et al. Prevalence and incidence of ischemic heart disease in multiple sclerosis: a population-based validation study. Mult Scler Relat Disord 2013;2:355-361.
20. Marrie RA, Fisk JD, Stadnyk KJ, et al. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia. Chronic Dis Inj Can 2014;34:145-153.
21. National Diabetes Surveillance System. Responding to the Challenge of Diabetes in Canada [online]. 2003. Available at: http://publications.gc.ca/collections/Collection/H39-4-21-2003E.pdf. Accessed January 10, 2006.
22. Rothman KJ, Greenland S, eds. Modern Epidemiology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.
23. Marrie RA, Yu N, Wei Y, Elliott L, Blanchard J. High rates of physician services utilization at least five years before multiple sclerosis diagnosis. Mult Scler 2013;19: 1113-1119.
24. Broemeling A, Watson DE, Prebtani F; on behalf of the Councillors of the Health Outcomes Steering Committee of the Health Council of Canada. Population patterns of chronic health conditions, co-morbidity and health care use in Canada: implications for policy and practice. Healthc Q 2008;11:70-76.
25. Langer-Gould A, Albers K, Van Den Eeden S, Nelson L. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler 2010;16:855-861.
26. Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler J 2014;21:282-293.
27. Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of cardiac, cerebrovascular and peripheral vascular disease in multiple sclerosis. Mult Scler 2015;21:318-331.
28. Marrie RA, Reider N, Cohen J, et al. The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review. Mult Scler 2015;21:332-341.
29. Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler 2015; 21:342-349.
30. Marrie RA, Reider N, Cohen J, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler 2015;21:305-317.
31. Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis 2014;75: 210-217.
32. Kerola AM, Kerola T, Kauppi MJ, et al. Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2013;72:1826-1829.
33. Sin DD, Cohen SB, Day A, Coxson H, Pare PD. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc 2007;4:671-674.
34. Benito-Leon J, Morales JM, Rivera-Navarro J. Healthrelated quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 2002;9:497-502.
35. Marrie RA, Elliott L, Marriott J, Cossoy M, Tennakoon A, Yu N. Comorbidity increases the risk of hospitalizations in multiple sclerosis. Neurology 2015;84:350-358.
36. Patti F, Nicoletti A, Pappalardo A, et al. Frequency and severity of headache is worsened by Interferon-b therapy in patients with multiple sclerosis. Acta Neurol Scand 2012;125:91-95.
37. Blanco-Kelly F, Matesanz F, Alcina A, et al. CD40: novel association with Crohns disease and replication in multiple sclerosis susceptibility. PLoS One 2010;5:e11520.
38. Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality: a review of recent evidence. Autoimmun Rev 2013;12:976-989.
39. Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of cancer in multiple sclerosis. Mult Scler 2015;21:294-304.